Home Total Iron Binding Capacity and Transferrin Concentration in the Assessment of Iron Status
Article
Licensed
Unlicensed Requires Authentication

Total Iron Binding Capacity and Transferrin Concentration in the Assessment of Iron Status

  • Ishmael Kasvosve and Joris Delanghe
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 40 Issue 10

Abstract

Transferrin concentration and total iron binding capacity (TIBC) are currently used to assess iron status. Although correlation between TIBC and transferrin is generally considered as good, conversion factors between the two analytes found in literature show large differences.

Although the price per test is lower for TIBC, there are a number of analytical advantages of serum transferrin. Due to binding of iron to other plasma proteins (mainly albumin), TIBC methods generally overestimate the iron binding capacity of transferrin. Moreover, no generic reference values are available for TIBC. In contrast to TIBC, internationally accepted interim reference ranges are available for serum transferrin. The introduction of the international CRM 470 protein standard material has lead to a significant reduction in interlaboratory variation for transferring measurements. In view of these observations, determination of transferrin concentration, rather than TIBC, is recommended. However, in non-European populations characterized by a marked genetic variation in transferrin (TF BC and TF CD variants), in certain cases, immunochemical determination of transferrin may lead to errors. In these populations, TIBC measurements may be preferred.

:
Published Online: 2005-06-01
Published in Print: 2002-10-29

Copyright © 2002 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. The 9th Asian Pacific Congress of Clinical Biochemistry
  2. Circulating DNA in Plasma and Serum: Biology, Preanalytical Issues and Diagnostic Applications
  3. Role of Steroid Hormones and Growth Factors in Breast Cancer
  4. Gene Polymorphism and Coronary Risk Factors in Indian Population
  5. Clinical Utility of Free Drug Monitoring
  6. Telomerase – a Potential Molecular Marker of Lung and Cervical Cancer
  7. Association of Polymorphisms in the Collagen Region of Human SP-A1 and SP-A2 Genes with Pulmonary Tuberculosis in Indian Population
  8. Effect of Hemodialysis on the Oxidative Stress and Antioxidants
  9. Total Iron Binding Capacity and Transferrin Concentration in the Assessment of Iron Status
  10. Increased Levels of Osteoprotegerin in Hemodialysis Patients
  11. Levels of Testosterone, Allopregnanolone and Homocysteine in Severe Hypothyroidism
  12. The Levels of Serum Vitamin C, Malonyldialdehyde and Erythrocyte Reduced Glutathione in Chronic Obstructive Pulmonary Disease and in Healthy Smokers
  13. Highly Specific, Simple and Rapid Method for the Determination of Malondialdehyde in Blood Using High-Performance Liquid Chromatography
  14. Precision and Accuracy of a HPLC Method for Measurement of Fecal Porphyrin Concentrations
  15. Continuous Age-Dependent Reference Ranges for Thyroid Hormones in Neonates, Infants, Children and Adolescents Established Using the ADVIA(r) Centaur(tm) Analyzer
  16. Diagnostic Value of Various Urine Tests in the Jordanian Population with Urinary Tract Infection
  17. Performance Evaluation of the Precision™ PCx™ Point-of-Care Blood Glucose Analyzer Using Discriminant Ratio Methodology
  18. Clinical Evaluation of a New Automated Anti-dsDNA Fluorescent Immunoassay
  19. Upper Reference Limits for Urinary Catecholamines, Metanephrines and 3-Methoxy-4-Hydroxymandelic Acid in Hypertensive Patients
  20. Growth Hormone Immunoassays: Proposal to Reduce Interlaboratory Variability
  21. Poetry, Images and Visions: William Blake
  22. Meetings and Awards
Downloaded on 6.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2002.176/html
Scroll to top button